Table 3

Estimating the savings of the Saúde em Nossas Mãos initiative

HAI typeProfileNLOSAC per bed-day (BRL$)AC per hospitalisation in BRL$ (95% CI)Estimation of HAIs preventedSaving (BRL$) (95% CI)
CLABSIAdult34021256653 103.19 (50 468–55 737)164787.4 million (83.1 to 91.7)
Paediatric1230279383 112.40 (63 000–103 224)867.1 million (10.5 to 17.2)
Neonatal1734234480 283.98 (71 257–89 310)20516.4 million (14.6 to 18.3)
VAPAdult55925243361 494.22 (59 235–63 752)3775232.1 million (223.6 to 240.6)
Paediatric1412642109 198.83 (NA)11412.4 million (NA)
Neonatal119222042 061.86 (NA)1184.9 million (NA)
CAUTIAdult11723203546 765.87 (43 130–50 401)137764.3 million (59.3 to 69.4)
Paediatric4393512136 330.91 (106 294–166 367)202.7 million (2.7 to 4.3)
Total (BRL$)427 742 620.78 (373.9 to 441.4 million)
Total (Intl$)175 304 352.77 (153.2 to 180.9 million)
  • AC, average cost; BRL$, real (Brazilian currency); CAUTI, catheter-associated urinary tract infection; CLABSI, central line-associated bloodstream infection; HAIs, healthcare-associated infections; Intl$, purchasing power parity (international dollar); LOS, mean length of stay (in days); N, number of patients analysed; NA, not applicable; VAP, ventilator-associated pneumonia.